Literature DB >> 33545922

Radiotherapy of granulomatosis with polyangiitis occurring in the eyelid: A case report and literature review.

Jinlong Wei1,2,3, Qin Zhao1,2,3, Min Yao4, Lingbin Meng5, Ying Xin6, Xin Jiang1,2,3.   

Abstract

INTRODUCTION: Granulomatosis with polyangiitis (GPA) is a chronic systemic vasculitis characterized by necrotizing granulomatous vasculitis. The disease mainly affects the middle and small blood vessels and mainly occurs in the upper respiratory tract (nose and paranasal sinuses), lower respiratory tract (lungs), and kidneys. Disease occurrence in the eyelid area is relatively rare. The standard GPA treatment is combination therapy with adrenocortical hormone and immunosuppressants. Radiotherapy as a treatment option for GPA has not been widely investigated. PATIENT CONCERNS: A 29-year-old man presented with a 1.0 × 1.0 cm mass without exophthalmos and decreased vision in the left lower eyelid. Computed tomography revealed a mass-like high-density shadow below the left eye with a computed tomography value of 80-108 U. DIAGNOSIS: The laboratory investigations revealed positive cytoplasmic antineutrophil cytoplasmic antibodies (titer = 1:40). Biopsy of the lower left eyelid mass revealed necrosis and granulomatous reaction with a large number of inflammatory cell infiltration. After consultation with the pathology department, the diagnosis was determined as left lower eyelid GPA.
INTERVENTIONS: The patient received 9MeV electron beam radiation therapy in the area of the left lower eyelid lesion. OUTCOMES: The lesion in the patient was significantly reduced and the symptom relieved obviously. No symptom recurrence or significant toxicity occurred during or after the treatment. The patient remains under routine follow-up.
CONCLUSION: We present a case of a male patient with GPA located exclusively in the eyelid area, who underwent successful radiotherapy and achieved a complete response. The lesson we learned from this case study is that for GPA patients, when the standard treatment model fails to achieve good results, novel treatments such as radiotherapy should be considered according to the situation.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33545922      PMCID: PMC7837942          DOI: 10.1097/MD.0000000000022794

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  17 in total

1.  Radiation therapy and mechanical dilation of endobronchial obstruction secondary to Wegener's granulomatosis.

Authors:  L E Eagleton; R B Rosher; A Hawe; R T Bilinsky
Journal:  Chest       Date:  1979-11       Impact factor: 9.410

2.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

Review 3.  Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.

Authors:  Luciana Breda; Manuela Nozzi; Sara De Sanctis; Francesco Chiarelli
Journal:  Semin Arthritis Rheum       Date:  2009-02-26       Impact factor: 5.532

4.  Regression of necrotizing scleritis in Wegener's granulomatosis after infliximab treatment.

Authors:  Matti Kontkanen; Leena Paimela; Kai Kaarniranta
Journal:  Acta Ophthalmol       Date:  2009-09-16       Impact factor: 3.761

Review 5.  Non-infectious orbital vasculitides.

Authors:  B Perumal; E H Black; F Levin; J J Servat
Journal:  Eye (Lond)       Date:  2012-02-24       Impact factor: 3.775

Review 6.  Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment.

Authors:  Cloé Comarmond; Patrice Cacoub
Journal:  Autoimmun Rev       Date:  2014-08-20       Impact factor: 9.754

7.  The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis.

Authors:  J K Rao; M Weinberger; E Z Oddone; N B Allen; P Landsman; J R Feussner
Journal:  Ann Intern Med       Date:  1995-12-15       Impact factor: 25.391

8.  B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.

Authors:  M Martinez Del Pero; A Chaudhry; R B Jones; P Sivasothy; P Jani; D Jayne
Journal:  Clin Otolaryngol       Date:  2009-08       Impact factor: 2.597

Review 9.  Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings.

Authors:  Karra Muller; Jonathan H Lin
Journal:  Arch Pathol Lab Med       Date:  2014-08       Impact factor: 5.534

Review 10.  The immunopathology of ANCA-associated vasculitis.

Authors:  Eoin F McKinney; Lisa C Willcocks; Verena Broecker; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2014-07-24       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.